https://www.sonnetbio.com/technology/publications The latest news released by Sonnet BioTherapeutics, Inc. en-us Equisolve https://d1io3yog0oux5.cloudfront.net/_1f9fc99531d9e3f3ae35f5961cd38397/sonnetbio/logo.png https://www.sonnetbio.com 88 31 https://www.sonnetbio.com/technology/publications/detail/6819/expansion-of-a-phase-1-study-of-son-1010-il12-fhab-adding-trabectedin-in-soft-tissue-sarcoma-trial-in-progress Tue, 11 Nov 2025 00:00:00 -0500 https://www.sonnetbio.com/technology/publications/detail/6819/expansion-of-a-phase-1-study-of-son-1010-il12-fhab-adding-trabectedin-in-soft-tissue-sarcoma-trial-in-progress https://www.sonnetbio.com/technology/publications/detail/6805/combination-immunotherapy-with-an-albumin-binding-interleukin-12-fusion-protein-that-extends-cytokine-half-life-targets-the-tumor-microenvironment-and-enhances-therapeutic-efficacy Tue, 25 Feb 2025 00:00:00 -0500 https://www.sonnetbio.com/technology/publications/detail/6805/combination-immunotherapy-with-an-albumin-binding-interleukin-12-fusion-protein-that-extends-cytokine-half-life-targets-the-tumor-microenvironment-and-enhances-therapeutic-efficacy https://www.sonnetbio.com/technology/publications/detail/6792/son-1010-an-albumin-binding-il-12-fusion-protein-that-improves-cytokine-half-life-targets-tumors-and-enhances-therapeutic-efficacy Wed, 04 Dec 2024 00:00:00 -0500 https://www.sonnetbio.com/technology/publications/detail/6792/son-1010-an-albumin-binding-il-12-fusion-protein-that-improves-cytokine-half-life-targets-tumors-and-enhances-therapeutic-efficacy https://www.sonnetbio.com/technology/publications/detail/6767/sb221-a-proof-of-concept-study-to-assess-the-combination-of-son-1010-il12-fhab-and-atezolizumab-in-patients-with-platinum-resistant-ovarian-cancer-trial-in-progress Mon, 03 Jun 2024 00:00:00 -0400 https://www.sonnetbio.com/technology/publications/detail/6767/sb221-a-proof-of-concept-study-to-assess-the-combination-of-son-1010-il12-fhab-and-atezolizumab-in-patients-with-platinum-resistant-ovarian-cancer-trial-in-progress https://www.sonnetbio.com/technology/publications/detail/6761/low-dose-interleukin-6-son-080-for-neuropathies-toxicology-and-clinical-plans Wed, 10 Apr 2024 00:00:00 -0400 https://www.sonnetbio.com/technology/publications/detail/6761/low-dose-interleukin-6-son-080-for-neuropathies-toxicology-and-clinical-plans https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1326927/full?utm_source=F-NTF&utm_medium=EMLX&utm_campaign=PRD_FEOPS_20170000_ARTICLE Fri, 01 Dec 2023 00:00:00 -0500 https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1326927/full?utm_source=F-NTF&utm_medium=EMLX&utm_campaign=PRD_FEOPS_20170000_ARTICLE https://www.sonnetbio.com/technology/publications/detail/6757/interim-analysis-of-a-phase-1-study-using-il12-fhab-with-optimized-pharmacokinetics Wed, 01 Nov 2023 00:00:00 -0400 https://www.sonnetbio.com/technology/publications/detail/6757/interim-analysis-of-a-phase-1-study-using-il12-fhab-with-optimized-pharmacokinetics https://www.sonnetbio.com/technology/publications/detail/6749/clinical-development-of-a-novel-form-of-interleukin-12-with-extended-pharmacokinetics Tue, 18 Apr 2023 00:00:00 -0400 https://www.sonnetbio.com/technology/publications/detail/6749/clinical-development-of-a-novel-form-of-interleukin-12-with-extended-pharmacokinetics https://www.sonnetbio.com/technology/publications/detail/6730/an-innovative-human-platform-for-targeted-delivery-of-bispecific-interleukins-to-tumors Fri, 08 Apr 2022 00:00:00 -0400 https://www.sonnetbio.com/technology/publications/detail/6730/an-innovative-human-platform-for-targeted-delivery-of-bispecific-interleukins-to-tumors https://www.sonnetbio.com/technology/publications/detail/6723/toxicity-profile-of-interleukin-12-attached-to-a-fully-human-albumin-binding-domain-fhab-in-cynomolgus-macaques Mon, 17 May 2021 00:00:00 -0400 https://www.sonnetbio.com/technology/publications/detail/6723/toxicity-profile-of-interleukin-12-attached-to-a-fully-human-albumin-binding-domain-fhab-in-cynomolgus-macaques https://www.sonnetbio.com/technology/publications/detail/6667/a-novel-strategy-to-produce-high-level-and-high-purity-of-bioactive-il15-fusion-proteins-from-mammalian-cells Wed, 01 Aug 2018 00:00:00 -0400 https://www.sonnetbio.com/technology/publications/detail/6667/a-novel-strategy-to-produce-high-level-and-high-purity-of-bioactive-il15-fusion-proteins-from-mammalian-cells https://www.sonnetbio.com/technology/publications/detail/6669/in-vivo-effect-of-albumin-binding-domains-abd-attached-to-immune-modulators Wed, 01 Nov 2017 00:00:00 -0400 https://www.sonnetbio.com/technology/publications/detail/6669/in-vivo-effect-of-albumin-binding-domains-abd-attached-to-immune-modulators https://www.sonnetbio.com/technology/publications/detail/6668/enhanced-efficacy-of-immune-modulators-with-albumin-binding-domains-abd Sun, 01 Oct 2017 00:00:00 -0400 https://www.sonnetbio.com/technology/publications/detail/6668/enhanced-efficacy-of-immune-modulators-with-albumin-binding-domains-abd